Allen Investment Management LLC Nektar Therapeutics Transaction History

Allen Investment Management LLC

  • $8.34 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 06, 2019
SELL
$16.91 - $36.27 $361,231 - $774,799
-21,362 Closed
0 $0
Q1 2019

May 10, 2019
BUY
$31.58 - $46.35 $674,611 - $990,128
21,362 New
21,362 $718,000
Q4 2018

Feb 05, 2019
SELL
$30.43 - $56.65 $706,189 - $1.31 Million
-23,207 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$57.4 - $108.44 $1.33 Million - $2.52 Million
23,207 New
23,207 $2.47 Million

Others Institutions Holding NKTR

# of Institutions
145
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $178M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Allen Investment Management LLC Portfolio

Follow Allen Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allen Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allen Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email